Kevin Van der Jeught

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 7

Top Venues

Nature biomedical engineering

Nature communications

Nature nanotechnology

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Zhuolong Zhou, Kevin Van der Jeught, Yuanzhang Fang, Tao Yu, Yujing Li, Zheng Ao, Sheng Liu, Lu Zhang, Yang Yang, Haniyeh Eyvani, Mary L Cox, Xiyu Wang, Xiaoming He, Guang Ji, Bryan P Schneider, Feng Guo, Jun Wan, Xinna Zhang, Xiongbin Lu
Author Correction: An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicity. Nature biomedical engineering (2023)
Yujing Li, Yifan Sun, Michael Kulke, Torsten Hechler, Kevin Van der Jeught, Tianhan Dong, Bin He, Kathy D Miller, Milan Radovich, Bryan P Schneider, Andreas Pahl, Xinna Zhang, Xiongbin Lu
Targeted immunotherapy for HER2-low breast cancer with 17p loss. Science translational medicine 13 (580) (2021)
Zhuolong Zhou, Kevin Van der Jeught, Yuanzhang Fang, Tao Yu, Yujing Li, Zheng Ao, Sheng Liu, Lu Zhang, Yang Yang, Haniyeh Eyvani, Mary L Cox, Xiyu Wang, Xiaoming He, Guang Ji, Bryan P Schneider, Feng Guo, Jun Wan, Xinna Zhang, Xiongbin Lu
An organoid-based screen for epigenetic inhibitors that stimulate antigen presentation and potentiate T-cell-mediated cytotoxicity. Nature biomedical engineering 5 (11) (2021)
Jiangsheng Xu, Yunhua Liu, Yujing Li, Hai Wang, Samantha Stewart, Kevin Van der Jeught, Pranay Agarwal, Yuntian Zhang, Sheng Liu, Gang Zhao, Jun Wan, Xiongbin Lu, Xiaoming He
Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer. Nature nanotechnology 14 (4) (2019)
Yujing Li, Yunhua Liu, Hanchen Xu, Guanglong Jiang, Kevin Van der Jeught, Yuanzhang Fang, Zhuolong Zhou, Lu Zhang, Michael Frieden, Lifei Wang, Zhenhua Luo, Milan Radovich, Bryan P Schneider, Yibin Deng, Yunlong Liu, Kun Huang, Bin He, Jin Wang, Xiaoming He, Xinna Zhang, Guang Ji, Xiongbin Lu
Heterozygous deletion of chromosome 17p renders prostate cancer vulnerable to inhibition of RNA polymerase II. Nature communications 9 (1) (2018)
Yunhua Liu, Jiangsheng Xu, Hyun Ho Choi, Cecil Han, Yuanzhang Fang, Yujing Li, Kevin Van der Jeught, Hanchen Xu, Lu Zhang, Michael Frieden, Lifei Wang, Haniyeh Eyvani, Yifan Sun, Gang Zhao, Yuntian Zhang, Sheng Liu, Jun Wan, Cheng Huang, Guang Ji, Xiongbin Lu, Xiaoming He, Xinna Zhang
Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancer. Nature communications 9 (1) (2018)
Kevin Van der Jeught, Stefaan De Koker, Lukasz Bialkowski, Carlo Heirman, Patrick Tjok Joe, Federico Perche, Sarah Maenhout, Sanne Bevers, Katrijn Broos, Kim Deswarte, Virginie Malard, Hamida Hammad, Patrick Baril, Thierry Benvegnu, Paul-Alain Jaffrès, Sander A A Kooijmans, Raymond Schiffelers, Stefan Lienenklaus, Patrick Midoux, Chantal Pichon, Karine Breckpot, Kris Thielemans
Dendritic Cell Targeting mRNA Lipopolyplexes Combine Strong Antitumor T-Cell Immunity with Improved Inflammatory Safety. ACS nano 12 (10) (2018)

Kevin Van der Jeught.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Kevin Van der Jeught